1. Home
  2. OMCL vs NVCR Comparison

OMCL vs NVCR Comparison

Compare OMCL & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OMCL
  • NVCR
  • Stock Information
  • Founded
  • OMCL 1992
  • NVCR 2000
  • Country
  • OMCL United States
  • NVCR Jersey
  • Employees
  • OMCL N/A
  • NVCR N/A
  • Industry
  • OMCL Computer Manufacturing
  • NVCR Medical/Dental Instruments
  • Sector
  • OMCL Technology
  • NVCR Health Care
  • Exchange
  • OMCL Nasdaq
  • NVCR Nasdaq
  • Market Cap
  • OMCL 2.0B
  • NVCR 1.8B
  • IPO Year
  • OMCL 2001
  • NVCR 2015
  • Fundamental
  • Price
  • OMCL $52.50
  • NVCR $18.10
  • Analyst Decision
  • OMCL Buy
  • NVCR Buy
  • Analyst Count
  • OMCL 8
  • NVCR 5
  • Target Price
  • OMCL $49.14
  • NVCR $26.60
  • AVG Volume (30 Days)
  • OMCL 539.1K
  • NVCR 1.3M
  • Earning Date
  • OMCL 10-30-2024
  • NVCR 10-30-2024
  • Dividend Yield
  • OMCL N/A
  • NVCR N/A
  • EPS Growth
  • OMCL N/A
  • NVCR N/A
  • EPS
  • OMCL N/A
  • NVCR N/A
  • Revenue
  • OMCL $1,064,205,999.00
  • NVCR $577,738,000.00
  • Revenue This Year
  • OMCL N/A
  • NVCR $16.26
  • Revenue Next Year
  • OMCL $5.21
  • NVCR $6.29
  • P/E Ratio
  • OMCL N/A
  • NVCR N/A
  • Revenue Growth
  • OMCL N/A
  • NVCR 14.63
  • 52 Week Low
  • OMCL $25.12
  • NVCR $10.87
  • 52 Week High
  • OMCL $55.75
  • NVCR $24.74
  • Technical
  • Relative Strength Index (RSI)
  • OMCL 69.56
  • NVCR 60.81
  • Support Level
  • OMCL $39.05
  • NVCR $15.89
  • Resistance Level
  • OMCL $55.75
  • NVCR $17.69
  • Average True Range (ATR)
  • OMCL 2.27
  • NVCR 1.01
  • MACD
  • OMCL 1.15
  • NVCR 0.14
  • Stochastic Oscillator
  • OMCL 80.54
  • NVCR 89.55

About OMCL Omnicell Inc. ($0.001 par value)

Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: